Abstract:Wilms tumor (WT) is a pediatric kidney cancer associated with poor outcomes in patients with unfavorable histological features such as anaplasia. Small non-coding RNAs, such as miRNAs, are known to be involved in WT pathogenesis. However, research on the clinical potential of blood-based miRNAs is limited. This study aimed to profile aberrantly expressed miRNAs in WT serum samples, evaluate their potential to differentiate standard-risk patients with favorable histology from those with anaplastic WTs, and assess their clinical value as minimally invasive biomarkers for WT detection. The study used next-generation sequencing (NGS) to analyze miRNA expressions in serum samples from 37 Egyptian children, including 10 healthy individuals, 14 with non-anaplastic WTs (favorable histology FH-WTs), and 13 with anaplastic WTs (unfavorable histology UnFH-WTs). Functional enrichment analysis was conducted to identify critical pathways and biological processes affected by dysregulated miRNAs, and a network was created for the most promising miRNA-target interactions linked to WT. The study identified a distinct miRNA expression signature of 45 miRNAs (3 upregulated and 42 downregulated) in WT serum samples compared to healthy controls, with 29 miRNAs exclusively dysregulated in FH-WTs and 6 miRNAs dysregulated solely in UnFH-WTs. These dysregulated miRNAs displayed significant enrichment in cancer-related pathways, such as PI3K/AKT, FOXO, and MAPK signaling. In relation to WT clinicopathological features, decreased levels of hsa-miR-2355-3p showed a significant positive correlation with clinical stage ( r = 0.6597, p = 0.0006) and WT metastasis ( r = 0.439, p = 0.021). The ROC curve analysis revealed that multiple dysregulated miRNAs in WT, specifically hsa-miR-7-5p, hsa-miR-146a-5p, hsa-miR-378a-3p, and hsa-miR-483-5p, exhibited high diagnostic potential for WT, with AUC values exceeding 0.86. Among WT histopathology types, the hsa-miR-1180-3p showed a 2.3 log2fold difference in expression between UnFH-WTs and FH-WTs, indicating its potential as a biomarker with 92% sensitivity and 85% specificity for identifying UnFH-WTs. Its target genes were enriched in pathways related to cell division and cell cycle regulation. In conclusion, hsa-miR-1180-3p could be a reliable blood-based biomarker for distinguishing WT histopathological types, and further research is needed to validate its clinical value.

A serum protein fingerprint in the diagnosis and prognosis of Wilms' tumors in children

Screening and identification of non-inflammatory specific protein markers in Wilms' tumor tissues.

Identification of Potential Serum Biomarkers for Wilms Tumor after Excluding Confounding Effects of Common Systemic Inflammatory Factors.

Identification of Proteins Associated with Pediatric Bilateral Wilms Tumor

The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.

Identification Of Apolipoprotein C-I As A Potential Wilms' Tumor Marker After Excluding Inflammatory Factors

[Detecting biomarkers from serum in nephroblastoma patients with support vector machine].

Screening of proteins associated with pediatric bilateral wilms tumor

Differential Protein Expression Between Wilms' Tumor and Embryonic Kidney Cells

Analysis of Secretory Protein Expression on Wilms' Tumor in Vitro and in Vivo by SELDI Technique

Identification of Novel Serum Biomarkers in Child Nephroblastoma Using Proteomics Technology

Screening and Identification of Post-Traumatic Stress-Related Serum Factors in Children with Wilms' Tumors

Screening and identification analysis of serum protein biomarkers in nephroblastoma

Identification of Differentially Expressed Inflammatory Factors in Wilms Tumors and Their Association with Patient Outcomes

Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors

Profiling of the serum MiRNAome in pediatric egyptian patients with wilms tumor

Diagnosis of pancreatic adenocarcinoma using protein chip technology.

Machine Learning-Based CT Radiomics Method for Identifying the Stage of Wilms Tumor in Children

Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor

Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis

Methylation changes and INS-IGF2 expression predict progression in early-stage Wilms tumor